TCF7L2 is a transcription factor involved in the Wnt signaling pathway and plays a key role in insulin secretion from pancreatic beta cells. Risk variants (e.g., rs7903146) are strongly associated with increased type 2 diabetes risk, as they impair glucose-stimulated insulin release. Evidence comes from large GWAS and functional studies showing a causal effect on beta-cell function. However, the effect size is moderate (odds ratio ~1.4) and modifiable by lifestyle factors such as diet and exercise. A DNA test alone has limited predictive value; clinically relevant measures include fasting glucose, HbA1c, and insulin levels. Personalized dietary advice based on TCF7L2 variants is not yet supported by robust randomized controlled trials.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-7e3455543e5946a79d611b4b